References
Wang GF, Yan YX, Xu N, et al. Predictive factors of type diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg. 2015;25:199–208.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation provides to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995;222:339–52.
Dixon JB, O’Brien PE. Selecting the optimal patient for LAP-BAND placement. Am J Surg. 2002;184:17–20.
Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237:751–8.
Rosenthal R, Li X, Samuel S, et al. Effects of sleeve gastrectomy on patients with diabetes mellitus. Surg Obes Related Dis. 2009;5:429–34.
Hall TC, Pellen MGC, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20:1245–50.
Lee WJ, Hur KY, Lakadawala M, et al. Gastro-intestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg. 2012;16:45–52.
Garcia-Caballero M, Valle M, Martinez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24–29 BMI patients with one anastomosis gastric bypass. Nutr Hosp. 2012;27:623–31.
Lee WJ, Chong K, Chen RJ, et al. Predictors of diabetes remission after bariatric surgery in Asian. Asian J Surg. 2012;35:67–73.
Lee WJ, Chong K, Ser KH, et al. C-peptide predicts the remission of type 2 diabetes after briatric surgery. Obes Surg. 2012;22:293–8.
Dixon J, Chung LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care. 2013;36:20–6.
Dixon J, Hur KJ, Lee WJ, et al. Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes. Diabet Med. 2013;30:e127–34.
Lakadawala M, Shaikh S, Bandukwala S, et al. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30–35) Indian patients with type 2 diabetes mellitus. Surg Obes Relat Dis. 2013;9:370–8.
Lee YC, Lee WJ, Liew PL. Predictors of remission of type 2 diabetes mellitus in obese patients after gastrointestinal surgery. Obesity Res Clin Practice. 2013;7:e494–500.
Robert M, Ferran-Gailliard C, Disse E, et al. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg. 2013;23:770–5.
Aarts EO, Janssen J, Janssen IMC, et al. Pre-operative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery. Obes Surg. 2013;23:867–73.
Ramos-Levi A, Matia P, Cabrerizo L, et al. C-peptide levels predict type 2 diabetes remission after bariatric surgery. Nutr Hosp. 2013;28:1599–603.
Nannipieri M, Baldi S, Mari D, et al. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Met. 2013;98:4391–9.
Jimenez A, Casamitjana R, Flores L, et al. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects. Ann Surg. 2013;257:894–9.
Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery. 2010;147:664–9.
Hayes MT, Hunt LA, Foo J, et al. A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en-Y gastric bypass. Obes Surg. 2011;21:910–9.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.
Lee WJ, Wang W, Lee YC, et al. Effects of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and < 35 Kg/m2. J Gastrointest Surg. 2008;12:945–52.
Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.
Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The diabetes surgery study randomized clinical trial. JAMA. 2013;309(21):2240–9.
Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Related Dis. 2013;9:379–84.
Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol. 2014;2:38–45.
Acknowledgments
This work was partly supported by a grant from Ming-Shen General Hospital (97-A-01)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Compliance with Ethical Standards
ᅟ
Conflict of Interest Statement
The authors declare that they have no competing interests.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
Does not apply.
Rights and permissions
About this article
Cite this article
Fang, YL., Almulaifi, A.M. & Lee, WJ. Letter to “Predictive Factors of Type 2 Diabetes Mellitus Remission Following Bariatric Surgery: a Meta-analysis”. OBES SURG 25, 2424–2425 (2015). https://doi.org/10.1007/s11695-015-1886-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-015-1886-1